Raghu Venkatramanamoorthy

653 total citations
20 papers, 528 citations indexed

About

Raghu Venkatramanamoorthy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Raghu Venkatramanamoorthy has authored 20 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Raghu Venkatramanamoorthy's work include Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Raghu Venkatramanamoorthy is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Raghu Venkatramanamoorthy collaborates with scholars based in United States and United Kingdom. Raghu Venkatramanamoorthy's co-authors include Lance K. Heilbrun, Mark M. Zalupski, Anthony F. Shields, Philip A. Philip, Shirish M. Gadgeel, Jawana M. Lawhorn‐Crews, Minsig Choi, Elisabeth I. Heath, Ulka N. Vaishampayan and Antoinette J. Wozniak and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Epidemiology Biomarkers & Prevention and Journal of Thoracic Oncology.

In The Last Decade

Raghu Venkatramanamoorthy

20 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raghu Venkatramanamoorthy United States 11 268 176 128 89 85 20 528
George Khoudari United States 10 202 0.8× 102 0.6× 139 1.1× 98 1.1× 164 1.9× 34 581
Ekaphop Sirachainan Thailand 12 264 1.0× 80 0.5× 84 0.7× 49 0.6× 88 1.0× 37 432
Lawrence M. Knab United States 16 309 1.2× 269 1.5× 238 1.9× 72 0.8× 350 4.1× 31 791
Gianna Mariotti Italy 14 114 0.4× 525 3.0× 153 1.2× 60 0.7× 113 1.3× 38 851
Sorbarikor Piawah United States 9 206 0.8× 80 0.5× 203 1.6× 124 1.4× 56 0.7× 18 510
Nynke Zwart Netherlands 16 194 0.7× 138 0.8× 191 1.5× 66 0.7× 159 1.9× 25 648
Lan Liu China 15 128 0.5× 192 1.1× 291 2.3× 244 2.7× 80 0.9× 47 658
Mahvish Muzaffar United States 13 348 1.3× 143 0.8× 97 0.8× 100 1.1× 88 1.0× 66 607
Feng-Che Kuan Taiwan 9 170 0.6× 135 0.8× 113 0.9× 68 0.8× 49 0.6× 11 438

Countries citing papers authored by Raghu Venkatramanamoorthy

Since Specialization
Citations

This map shows the geographic impact of Raghu Venkatramanamoorthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghu Venkatramanamoorthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghu Venkatramanamoorthy more than expected).

Fields of papers citing papers by Raghu Venkatramanamoorthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghu Venkatramanamoorthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghu Venkatramanamoorthy. The network helps show where Raghu Venkatramanamoorthy may publish in the future.

Co-authorship network of co-authors of Raghu Venkatramanamoorthy

This figure shows the co-authorship network connecting the top 25 collaborators of Raghu Venkatramanamoorthy. A scholar is included among the top collaborators of Raghu Venkatramanamoorthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghu Venkatramanamoorthy. Raghu Venkatramanamoorthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammad, Nazik, Lance K. Heilbrun, Philip A. Philip, et al.. (2010). CA19‐9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy. Asia-Pacific Journal of Clinical Oncology. 6(2). 98–105. 34 indexed citations
2.
Zafar, Syed F., Lance K. Heilbrun, Prakash Vishnu, et al.. (2010). Participation and survival of geriatric patients in Phase I clinical trials: The Karmanos Cancer Institute (KCI) experience. Journal of Geriatric Oncology. 2(1). 18–24. 19 indexed citations
3.
Choi, Minsig, Lance K. Heilbrun, Raghu Venkatramanamoorthy, et al.. (2010). Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 33(3). 257–261. 74 indexed citations
4.
Narasimhan, Kailash, Ömer Küçük, Ho-Sheng Lin, et al.. (2009). Sinonasal Mucosal Melanoma: A 13-Year Experience at a Single Institution. Skull base. 19(4). 255–262. 37 indexed citations
5.
Heilbrun, Lance K., et al.. (2009). Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer. Case Reports in Oncology. 2(3). 220–228. 1 indexed citations
6.
Hammad, Nazik, P. A. Philip, Anthony F. Shields, et al.. (2009). A retrospective review of squamous cell carcinoma of the anal canal in HIV-positive and HIV-negative patients. Journal of Clinical Oncology. 27(15_suppl). e15586–e15586. 1 indexed citations
7.
Woźniak, Agnieszka, Gregory P. Kalemkerian, Shirish M. Gadgeel, et al.. (2009). A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). e19099–e19099. 3 indexed citations
8.
El-Rayes, B. F., Brijeshkumar S. Patel, Mark M. Zalupski, et al.. (2009). A phase II study of bevacizumab, docetaxel, and oxaliplatin in gastric and GEJ cancer. Journal of Clinical Oncology. 27(15_suppl). 4563–4563. 10 indexed citations
9.
Gadgeel, Shirish M., Martin J. Edelman, Manuel Valdivieso, et al.. (2009). Cediranib, a VEGF receptor 1, 2, and 3 inhibitor, and pemetrexed in patients (pts) with recurrent non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). e19007–e19007. 28 indexed citations
10.
Gadgeel, Shirish M., Antoinette J. Wozniak, John C. Ruckdeschel, et al.. (2008). Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(11). 1293–1300. 7 indexed citations
11.
El-Rayes, B. F., L. K. Heilbrun, P. A. Philip, et al.. (2008). A comparison of advanced pancreatic cancer patients treated on clinical trials with those from a SEER registry over an 18 year period. Journal of Clinical Oncology. 26(15_suppl). 4628–4628. 1 indexed citations
12.
Wozniak, Antoinette J., Lance K. Heilbrun, Ömer Küçük, et al.. (2007). Mature Results of a Phase II Trial of Gemcitabine/Paclitaxel Given Every 2 Weeks in Patients with Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 8(5). 313–318. 3 indexed citations
13.
14.
Littrup, Peter J., Hussein D. Aoun, Daniel L. Noujaim, et al.. (2007). CT-guided Percutaneous Cryotherapy of Renal Masses. Journal of Vascular and Interventional Radiology. 18(3). 383–392. 112 indexed citations
15.
El‐Rayes, Bassel F., Mark M. Zalupski, Ann M. Ferris, et al.. (2007). Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 61(2). 283–289. 19 indexed citations
16.
Djurić, Zora, Gang Chen, Jianwei Ren, et al.. (2007). Effects of High Fruit-Vegetable and/or Low-Fat Intervention on Breast Nipple Aspirate Fluid Micronutrient Levels. Cancer Epidemiology Biomarkers & Prevention. 16(7). 1393–1399. 13 indexed citations
17.
Djurić, Zora, et al.. (2006). Relationships of psychosocial factors to dietary intakes of preadolescent girls from diverse backgrounds. Maternal and Child Nutrition. 2(2). 79–90. 6 indexed citations
18.
Philip, P. A., et al.. (2006). A retrospective review of anal squamous cell carcinoma in HIV positive and HIV negative patients. Journal of Clinical Oncology. 24(18_suppl). 4153–4153. 3 indexed citations
19.
El-Rayes, B. F., Mark M. Zalupski, Anthony F. Shields, et al.. (2005). A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer. Investigational New Drugs. 23(6). 583–590. 75 indexed citations
20.
Chen, Gang, et al.. (2004). Effects of Low-Fat and/or High Fruit-and-Vegetable Diets on Plasma Levels of 8-Isoprostane-F2αin the Nutrition and Breast Health Study. Nutrition and Cancer. 50(2). 155–160. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Khoudari Breakdown of academic impact, for papers by Ekaphop Sirachainan Breakdown of academic impact, for papers by Lawrence M. Knab Breakdown of academic impact, for papers by Gianna Mariotti Breakdown of academic impact, for papers by Sorbarikor Piawah Breakdown of academic impact, for papers by Nynke Zwart Breakdown of academic impact, for papers by Lan Liu Breakdown of academic impact, for papers by Mahvish Muzaffar Breakdown of academic impact, for papers by Feng-Che Kuan
Rankless by CCL
2026